Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Another big one is muscle loss. A new ... weight loss,” Gerhart-Hines said. He explained that GLP-1 agonists don’t work quite as well for weight loss in people with diabetes because the drug ...

Novo Nordisk (NYSE:NVO)'s new weight loss drug CagriSema missed the company's ... which has been available since 2021. Novo Nordisk then introduced CagriSema that is basically an upgrade version ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss ... 2021 to December 2023, of which 58.9% were female. The overall prevalence of discontinuation of GLP-1 ...

Compounded by the equally sudden banning of the weight loss drug, phen-fen (phentermine-fenfluramine ... there remained no new promising pharmaceutical agents addressing obesity.

The U.S.-listed shares of Novo Nordisk A.S. were plunging toward their worst day in decades on Friday after the results from a late-stage trial showed that the Danish company’s new weight-loss ...

Kennedy, who very well could become Oz's boss if they are both approved by the Senate, appeared to scale back his criticism of the new weight-loss drug amid his efforts to court support for his ...

Dr. James Grant, the chief medical officer at Blue Cross Blue Shield of Michigan, said the insurer said it felt “forced” to reduce coverage of the new weight loss drugs for some members ...

A healthcare worker holds weight-loss drug Ozempic. In the ongoing fight against obesity, a growing epidemic with grave medical consequences, a new class of weight loss medications offers ...

Novo Nordisk (NYSE:NVO)'s new weight loss drug CagriSema missed the company's target of reducing ... which has been available since 2021. Novo Nordisk then introduced CagriSema that is basically an ...